Pharma Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Affibody AB
Affibody appoints Ulf Boberg as chief executive
July 4th, 2006
Affibody AB announced that Ulf Boberg has been appointed CEO as of June 1, 2006. Ulf Boberg, who joined Affibody in January 2006 as senior VP, Development, replaces Carl-Johan Dalsgaard who has been acting CEO of Affibody since December 2005. Dalsgaard is a partner of Affibody's largest shareholder HealthCap and will remain a non-executive board member of Affibody. Boberg holds a PhD in medical science, an MBA from Uppsala University and has 18 years experience from the pharmaceutical and biotechnology industry. Most recently, Boberg was CEO of Global Genomics AB. Before that, he held the senior roles of vice president and head of the Development...
Source: Pharma Law Weekly (2006-07-04)
|
